Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Articles|June 17, 2021

Psychiatry Comic: Smart Phone

Author(s)Jonny Hawkins

That's one smart phone!

Jonny Hawkins is a cartoonist, whose latest book, Laughter Therapy: Good Medicine to Make Your Heart Glad, is available now.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Comugnero Silvana/Adobe Stock

Institutional Narcissism and Renewal: Tarot Insights into Residency Training and Academic Leadership, Part 2

ByAmilcar Arnaldo Tirado, MD, MBA

March 4th 2026

In this 2-part series, a psychiatrist explores the connections between hostage films and psychiatry.

Do Hostage Films Help? Part 2: Movies and Psychiatry: Exploring Hostages & Heroics

BySharon Packer, MD

June 11th 2024

In this 2-part series, a psychiatrist explores the connections between hostage films and psychiatry.

Do Hostage Films Help? Part I: The Movies of Our Lives: How I Happened Upon Hostage Films

BySharon Packer, MD

May 20th 2024

"As we commemorate Black History Month, it is an opportune time to highlight the contributions of Black clinicians while acknowledging past and current shortcomings as well as the imperative to strive for improved equity for clinicians and patients alike."

Black History Month

ByMike Hennessy Jr

February 14th 2024

“In the realm of psychiatry, the therapeutic value of poetry lies in its ability to transcend the limitations of prose, offering a space for the unsayable and the ineffable.”

Bella, Horrida Bella

ByCaleb Rashidian, DO

January 31st 2024

Latest CME

Jersey City Psychiatry

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

Trending on Psychiatric Times

The Postmodern Worldview and Contemporary Psychiatry

Choosing Sexual Function-Sparing Medications

DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD

New Phase 2 Clinical Trial Initiating in 2027: Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose